What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. It has been the subject of extensive preclinical research since the 1990s, with over 100 published studies investigating its biological activity.
The peptide's sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is stable in human gastric juice, which is unusual for peptides of this size and has made it a subject of particular interest in tissue repair research.
Research Applications
BPC-157 has been studied in laboratory and animal models across several areas:
Tissue repair and wound healing — Multiple rodent studies have demonstrated accelerated healing of tendons, ligaments, muscles, and skin. A 2010 study published in the Journal of Orthopaedic Research found that BPC-157 promoted tendon healing in a rat model by stimulating the outgrowth of tendon fibroblasts.
Gastrointestinal protection — As its name suggests, BPC-157 originates from a gastric protection pathway. Research has shown protective effects against various forms of gastrointestinal damage in animal models, including ulcers induced by NSAIDs, alcohol, and stress.
Angiogenesis — Several studies have reported that BPC-157 promotes the formation of new blood vessels (angiogenesis), which is a key mechanism in tissue repair. This has been observed in both in vitro and in vivo models.
Nervous system — Preliminary research has explored BPC-157's interaction with the nitric oxide (NO) system and dopaminergic pathways, though this research remains in early stages.
Important Caveats
It is essential to note that:
- No human clinical trials have been completed for BPC-157 as of 2026
- All published research has been conducted in animal models or in vitro
- The peptide is not approved for therapeutic use in any jurisdiction
- Extrapolating animal research to human outcomes is not scientifically valid without clinical data
What to Look for When Sourcing
When selecting BPC-157 for laboratory research, key quality indicators include:
-
Purity verification — Look for HPLC (High-Performance Liquid Chromatography) results showing ≥98% purity. Mass spectrometry confirmation of molecular identity is equally important.
-
Certificate of Analysis (CoA) — Every batch should come with a CoA matched to its specific lot number, not a generic document.
-
Cold-chain handling — BPC-157 is sensitive to heat and should be stored at −20°C. Ensure your supplier maintains temperature-controlled shipping.
-
Lyophilised format — The peptide should be supplied as a lyophilised (freeze-dried) powder for maximum stability.
At Aevo, every batch of BPC-157 is independently assayed to ≥98% purity by HPLC and mass spectrometry, with cold-chain shipping across the UAE.
Published Research References
- Staresinic, M., et al. (2003). "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon." Journal of Orthopaedic Research, 21(6), 976-983.
- Sikiric, P., et al. (2018). "Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology, 16(5), 566-583.
- Chang, C.H., et al. (2011). "The promoting effect of pentadecapeptide BPC 157 on tendon healing." International Orthopaedics, 35(3), 421-426.
All products referenced are for laboratory research use only. Not for human consumption.